Downregulation of A 1 and A 2B adenosine receptors in human trisomy 21 mesenchymal cells from first-trimester chorionic villi

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1822, Issue 11, 2012, Pages 1660-1670

  Gessi, Stefania ^a   Merighi, Stefania ^a   Stefanelli, Angela ^a   Mirandola, Prisco ^b   Bonfatti, Alessandra ^a   Fini, Sergio ^a   Sensi, Alberto ^a,c   Marci, Roberto ^a   Varani, Katia ^a   Borea, Pier Andrea ^a   Vesce, Fortunato ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c AUSL   (Italy)

Author keywords

Adenosine receptors; Angiogenesis; Mesenchymal stem cells; Trisomy 21

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NITRIC OXIDE; VASCULOTROPIN;

ANEUPLOIDY; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL STRUCTURE; CHORION VILLUS SAMPLING; CONTROLLED STUDY; DOWN REGULATION; ENZYME RELEASE; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MESENCHYME CELL; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; TRISOMY 21;

ABORTION, SPONTANEOUS; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ANEUPLOIDY; CHORIONIC VILLI; DOWN SYNDROME; FEMALE; GENE EXPRESSION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MESODERM; NITRIC OXIDE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; RECEPTOR, ADENOSINE A1; RECEPTOR, ADENOSINE A2B; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84865052094     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2012.07.013     Document Type: Article

References (39)

1. Vesce F., Scapoli C., Giovannini G., Tralli L., Gotti G., Valerio A., Piffanelli A. Cytokine imbalance in pregnancies with fetal chromosomal abnormalities. Hum. Reprod. 2002, 17:803-808.
2. Levine R.J., Maynard S.E., Qian C., Lim K.H., England L.J., Yu K.F., Schisterman E.F., Thadhani R., Sachs B.P., Epstein F.H., Sibai B.M., Sukhatme V.P., Karumanchi S.A. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 2004, 350:672-683.
3. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., Declercq C., Pawling J., Moons L., Collen D., Risau W., Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996, 380:435-439.
4. Simon M.C., Keith B. The role of oxygen availability in embryonic development and stem cell function. Nat. Rev. Mol. Cell Biol. 2008, 9:285-296.
5. Fredholm B.B., IJzerman A.P., Jacobson K.A., Linden J., Müller C.E. International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors-an update. Pharmacol. Rev. 2011, 63:1-34.
6. Escudero C., Sobrevia L. A hypothesis for preeclampsia: adenosine and inducible nitric oxide synthase in human placental microvascular endothelium. Placenta 2008, 29:469-483.
7. George E., Cockrell K., Adair H., Granger J.P. Regulation of sFlt-1 and VEGF secretion by adenosine under hypoxic conditions in rat placental villous explants. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, 299:R1629-R1633.
8. Fox I., Kurpis L. Binding characteristics of an adenosine receptor in human placenta. J. Biol. Chem. 1983, 258:6952-6955.
9. Schocken D., Schneider M. Use of multiple radioligands to characterize adenosine receptors in human placenta. Placenta 1986, 7:339-348.
10. Masnikosa R., Nikolić A., Nedić O. Affinity modulation of human placental insulin and insulin-like growth factor receptors by lectins. J. Biochem. 2008, 143:813-820.
11. Gessi S., Fogli E., Sacchetto V., Merighi S., Varani K., Preti D., Leung E., Maclennan S., Borea P.A. Adenosine modulates HIF-1α, VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cells. Arterioscler. Thromb. Vasc. Biol. 2010, 30:90-97.
12. Poloni A., Rosini V., Mondini E., Maurizi G., Mancini S., Discepoli G., Biasio S., Battaglini G., Berardinelli E., Serrani F., Leoni P. Characterization and expansion of mesenchymal progenitor cells from first-trimester chorionic villi of human placenta. Cytotherapy 2008, 10:690-697.
13. Mirandola P., Gobbi G., Masselli E., Micheloni C., Di Marcantonio D., Queirolo V., Chiodera P., Meschi T., Vitale M. Protein kinase Cε regulates proliferation and cell sensitivity to TGF-1β of CD4+ T lymphocytes: implications for Hashimoto thyroiditis. J. Immunol. 2011, 187:4721-4732.
14. Merighi S., Gessi S., Varani K., Simioni C., Fazzi D., Mirandola P., Borea P.A. Cannabinoid CB(2) receptor modulates microglial cells stimulated with lypopolysaccharide: role of ERK-1/2 kinase signalling in nitric oxide release. Br. J. Pharmacol. 2012, 165:1773-1788.
15. Renaud S.J., Cotechini T., Quirt J.S., Macdonald-Goodfellow S.K., Othman M., Graham C.H. Spontaneous pregnancy loss mediated by abnormal maternal inflammation in rats is linked to deficient uteroplacental perfusion. J. Immunol. 2011, 186:1799-1808.
16. Hitoglou S., Zournatzi V., Gougoustamou D., Hatzistilianou M., Tzafettas J. Adenosine deaminase activity and its isoenzyme pattern in women with recurrent spontaneous abortions. Gynecol. Obstet. Invest. 2004, 58:126-129.
17. Blackburn M.R., Wubah J.A., Chunn J.L., Thompson L.F., Knudsen T.B. Transitory expression of the A2B adenosine receptor during implantation chamber development. Dev. Dyn. 1999, 216:127-136.
18. Perni U., Sezen D., Bongiovanni A.M., Linhares I.M., Skupski D., Witkin S.S. Endogenous adenosine down-modulates mid-trimester intra-amniotic tumor necrosis factor-α production. Am. J. Reprod. Immunol. 2009, 62:232-237.
19. Linden J., Thai T., Figler H., Jin X., Robeva A.S. Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells. Mol. Pharmacol. 1999, 56:705-713.
20. von Versen-Höynck F., Rajakumar A., Bainbridge S.A., Gallaher M.J., Roberts J.M., Powers R.W. Human placental adenosine receptor expression is elevated in preeclampsia and hypoxia increases expression of the A2A receptor. Placenta 2009, 30:434-442.
21. Varani K., Vincenzi F., Tosi A., Targa M., Masieri F.F., Ongaro A., De Mattei M., Massari L., Borea P.A. Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes. Br. J. Pharmacol. 2010, 160:101-115.
22. Kim Y.H., Hwang H.S., Kim Y.T., Kim H.S., Park Y.W. Modulation of matrix metalloproteinase secretion by adenosine A3 receptor in preeclamptic villous explants. Reprod. Sci. 2008, 15:939-949.
23. Wendler C.C., Amatya S., McClaskey C., Ghatpande S., Fredholm B.B., Rivkees S.A. A1 adenosine receptors play an essential role in protecting the embryo against hypoxia. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:9697-9702.
24. Rivkees S.A., Wendler C.C. Adverse and protective influences of adenosine on the newborn and embryo: implications for preterm white matter injury and embryo protection. Pediatr. Res. 2011, 69:271-278.
25. Buscariollo D.L., Breuer G.A., Wendler C.C., Rivkees S.A. Caffeine Acts via A1 Adenosine Receptors to Disrupt Embryonic Cardiac Function. PLoS One 2011, 6:e28296.
26. Grant M.B., Tarnuzzer R.W., Caballero S., Ozeck M.J., Davis M.I., Spoerri P.E., Feoktistov I., Biaggioni I., Shryock J.C., Belardinelli L. Adenosine receptor activation induces vascular endothelial growth factor in human retinal endothelial cells. Circ. Res. 1999, 85:699-706.
27. Feoktistov I., Goldstein A.E., Ryzhov S., Zeng D., Belardinelli L., Voyno-Yasenetskaya T., Biaggioni I. Differential expression of adenosine receptors in human endothelial cells: role of A2B receptors in angiogenic factor regulation. Circ. Res. 2002, 90:531-538.
28. Yang D., Chen H., Koupenova M., Carroll S.H., Eliades A., Freedman J.E., Toselli P., Ravid K. A new role for the A2b adenosine receptor in regulating platelet function. J. Thromb. Haemost. 2010, 8:817-827.
29. Yang D., Koupenova M., McCrann D.J., Kopeikina K.J., Kagan H.M., Schreiber B.M., Ravid K. The A2b adenosine receptor protects against vascular injury. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:792-796.
30. Donoso M.V., López R., Miranda R., Briones R., Huidobro-Toro J.P. A2B adenosine receptor mediates human chorionic vasoconstriction and signals through arachidonic acid cascade. Am. J. Physiol. Heart Circ. Physiol. 2005, 288:H2439-H2449.
31. Pipitone S., Garofalo C., Corsello G., Mongiovì M., Piccione M., Maresi E., Sperandeo V. Abnormalities of the umbilico-portal venous system in Down syndrome: a report of two new patients. Am. J. Med. Genet. 2003, 120A:528-532.
32. Clark A.N., Youkey R., Liu X., Jia L., Blatt R., Day Y.J., Sullivan G.W., Linden J., Tucker A.L. A1 adenosine receptor activation promotes angiogenesis and release of VEGF from monocytes. Circ. Res. 2007, 101:1130-1138.
33. Lima F.O., Souza G.R., Jr Verri W.A., Parada C.A., Ferreira S.H., Cunha F.Q., Cunha T.M. Direct blockade of inflammatory hypernociception by peripheral A1 adenosine receptors: involvement of the NO/cGMP/PKG/KATP signaling pathway. Pain 2010, 151:506-515.
34. Vásquez G., Sanhueza F., Vásquez R., González M., San Martín R., Casanello P., Sobrevia L. Role of adenosine transport in gestational diabetes-induced L-arginine transport and nitric oxide synthesis in human umbilical vein endothelium. J. Physiol. 2004, 560:111-122.
35. Tranquilli A.L., Bezzeccheri V., Scagnoli C., Mazzanti L., Garzetti G.G. Amniotic levels of vascular endothelial growth factor and nitric oxide at the second trimester in Down's syndrome. J. Matern-Fetal Neonatal Med. 2003, 13:28-31.
36. Salvolini E., Orciani M., Lucarini G., Vignini A., Tranquilli A.L., Di Primio R. VEGF and nitric oxide synthase immunoexpression in Down's syndrome amniotic fluid stem cells. Eur. J. Clin. Invest. 2011, 41:23-29.
37. Baek K.H., Zaslavsky A., Lynch R.C., Britt C., Okada Y., Siarey R.J., Lensch M.W., Park I.H., Yoon S.S., Minami T., Korenberg J.R., Folkman J., Daley G.Q., Aird W.C., Galdzicki Z., Ryeom S. Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature 2009, 459:1126-1130.
38. Vesce F., Scapoli C., Giovannini G., Piffanelli A., Geurts-Moespot A., Sweep F.C. Plasminogen activator system in serum and amniotic fluid of euploid and aneuploid pregnancies. Obstet. Gynecol. 2001, 97:404-408.
39. Vesce F., Farina A., Giorgetti M., Jorizzo G., Bianciotto A., Calabrese O., Mollica G. Increased incidence of preeclampsia in pregnancies complicated by fetal malformation. Gynecol. Obstet. Invest. 1997, 44:107-111.